Mark Alan Goldberg - Insider Trading & Ownership

Entity
Individual
Location
128 Spring Street, Suite 520, Lexington, MA
Summary
The estimated net worth of Mark Alan Goldberg is at least $2.03M dollars as of June 14, 2024. Mark Alan Goldberg is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $1.92M. Mark Alan Goldberg is the Director of GLYCOMIMETICS INC and owns shares of GLYCOMIMETICS INC (GLYC) stock worth about $109K.
All Insider Reports
All Insider Reports

Ownership of Mark Alan Goldberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Director $1.92M Jun 12, 2024
GLYC GLYCOMIMETICS INC Director $109K May 1, 2024
IMGN ImmunoGen, Inc. Director $0 Feb 12, 2024
IDRA Aceragen, Inc. Director Jun 23, 2022

Insider Transactions Reported by Mark Alan Goldberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.